Race disparities between black and white women in the incidence, treatment, and prognosis of endometrial cancer

Cancer Control

Volumn 16, Issue 1, 2009, Pages 53-56

  Allard, Jay E ^a   Maxwell, G Larry ^a,b  

^a Waller Reed Array Medical Center   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER THERAPY; CARDIOVASCULAR DISEASE; COMORBIDITY; DIABETES MELLITUS; ENDOMETRIUM CANCER; HUMAN; HYSTERECTOMY; MUTATION; OBESITY; PATIENT CARE; PROGNOSIS; RACE DIFFERENCE; SURGERY; AFRICAN AMERICAN; CAUCASIAN; CLINICAL PRACTICE; ENDOMETRIUM TUMOR; ETHNOLOGY; FEMALE; GENETICS; HEALTH CARE DELIVERY; REVIEW; SOCIOECONOMICS; UNITED STATES;

AFRICAN AMERICANS; COMORBIDITY; ENDOMETRIAL NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PROGNOSIS; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 61449446809     PISSN: 10732748     EISSN: 15262359     Source Type: Journal    
DOI: 10.1177/107327480901600108     Document Type: Article

References (31)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58(2):71-98. Epub 2008 Feb 20.
2. Kjerulff K, Langenberg P, Guzinski G. The socioeconomic correlates of hysterectomies in the United States. Am J Public Health. 1993;83(1 ):106-108.
3. Sherman ME, Garreon JD, Lacey JV Jr, et al. Impact of hysterectomy on endometrial carcinoma rates in the United States. J Natl Cancer inst. 2005 ;97(22): 1700-1702.
4. Ghafoor A, Jemal A, Cokkinides V, et al. Cancer statistics for African Americans. CA Cancer J Clin. 2002;52(6):326-341.
5. Ueda SM, Kapp DS, Cheung MK, et al. Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths. Am J Obstet Gynecol. 2008;198(2):218.e1-e6.
6. Freeman HP. Commentary on the meaning of race in science and society. Cancer Epidemiol Biomarkers Prev. 2003;12(3):232s-236s.
7. Liu JR, Conaway M, Rodriguez GC, et al. Relationship between race and interval to treatment in endometrial cancer. Obstet Gynecol. 1995;86(4 Pt 1):486-490.
8. Madison T, Schottenfeld D, James SA, et al. Endometrial cancer: socioeconomic status and racial/ethnic differences in stage at diagnosis, treatment, and survival. Am J Public Health. 2004;94(12):2104-2111.
9. Cossrow N, Falkner B. Race/ethnic issues in obesity and obesity-related comorbidities. J Clin Endocrinol Metab. 2004;89(6):2590-2594.
10. American Cancer Society. Cancer Facts & Figures for African Americans 2005-2006. http://www.cancer.org/downloads/STT/CAFF2005AACorr PWSecured.pdf. Accessed August 22, 2008.
11. Schouten LJ, Goldbohm RA, van den Brandt PA. Anthropometry, physical activity, and endometrial cancer risk: results from the Netherlands Cohort Study. J Natl Cancer Inst. 2004;96(21):1835-1638.
12. Colbert LH, Lacey JV Jr, Schairer C, et al. Physical activity and risk of endometrial cancer in a prospective cohort study (United States). Cancer Causes Control. 2003;14(6):559-567.
13. Brancati FL, Kao WH, Folsom AR, et al. Incident type 2 diabetes mellitus in African American and white adults: the Atherosclerosis Risk in Communities Study. JAMA. 2000;283(17):2253-2259.
14. Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev. 2002;11(12):1531-1543.
15. Papanas N, Giatromanolaki A, Galazios G, et al. Endometrial carcinoma and diabetes revisited. Eur J Gynaecol Oncol. 2006;27(5):505-508.
16. Folsom AR, Anderson KE, Sweeney C, et al. Diabetes as a risk factor for death following endometrial cancer. Gynecol Oncol. 2004;94(3):740-745.
17. Weiss JM, Saltzman BS, Doherty JA, et al. Risk factors for the incidence of endometrial cancer according to the aggressiveness of disease. Am J Epidemiol. 2006;164(1):56-62. Epub 2006 May 4.
18. Hicks ML, Phillips JL, Parham G, et al. The National Cancer Data Base report on endometrial carcinoma in African-American women. Cancer. 1998;83(12):2629-2637.
19. Brooks SE, Ahn J, Mullins CD, et al. Health care cost and utilization project analysis of comorbid illness and complications for patients undergoing hysterectomy for endometrial carcinoma. Cancer. 2001;92(4):950-958.
20. Randall TC, Armstrong K. Differences in treatment and outcome between African-American and white women with endometrial cancer. J Clin Oncol. 2003:21 (22):4200-4206.
21. Trimble EL, Harlan LC, Clegg LX, et al. Pre-operative imaging, surgery and adjuvant therapy for women diagnosed with cancer of the corpus uteri in community practice in the United States. Gynecol Oncol. 2005; 96(3):741-748.
22. Roland PY, Kelly FJ, Kulwicki CY, et al. The benefits of a gynecologic oncologist: a pattern of care study for endometrial cancer treatment. Gynecol Oncol. 2004:93(1):125-130.
23. Macdonald OK, Sause WT, Lee RJ, et al. Does oncologic specialization influence outcomes following surgery in early stage adenocarcinoma of the endometrium? Gynecol Oncol. 2005;99(3):730-735. Epub 2005 Sep 1.
24. Plaxe SC, Saltzstein SL. Impact of ethnicity on the incidence of high-risk endometrial carcinoma. Gynecol Oncol. 1997;65(1):8-12.
25. Sherman ME, Devesa SS. Analysis of racial differences in incidence, survival and mortality for malignant tumors of the uterine corpus. Cancer. 2003;98(1):176-186.
26. Maxwell GL, Tian C, Risinger J, et al. Racial disparity in survival among patients with advanced/recurrent endometrial adenocarcinoma: a Gynecologic Oncology Group study. Cancer. 2006;107(9):2197-2205.
27. Kohler MF, Berchuck A, Davidoff AM, et al. Overexpression and mutation of p53 in endometrial carcinoma. Cancer Res. 1992;52(6):1622-1627.
28. Santin AD, Bellone S, Siegel ER, et al. Racial differences in the over-expression of epidermal growth factor type II receptor (HER2/neu): a major prognostic indicator in uterine serous papillary cancer. Am J Obstet Gynecol. 2005;192(3):813-818.
29. Maxwell GL, Risinger Jl, Hayes KA, et al. Racial disparity in the frequency of PTEN mutations, but not microsatellite instability, in advanced endometrial cancers. Clin Cancer Res. 2000;6(8):2999-3005.
30. Powell MA, Mutch DG, Rader JS, et al. Ribosomal DNA methylation in patients with endometrial carcinoma: an independent prognostic marker. Cancer. 2002;94(11):2941-2952.
31. US Bureau of the Census, Current Population Reports, Series P23-194. Population Profile of the United States: 1997. Washington, DC: US Government Printing Office; 1998. http://www.census.goV/prod/3/98pubs/ p23-194.pdf. Accessed August 22, 2008.